|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 11400 TOMAHAWK CREEK PARKWAY |
Address2 |
|
City | LEAWOOD |
State | KS |
Zip Code | 66211-2672 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 1342-12
|
||||||||
|
6. House ID# 321800000
|
TYPE OF REPORT | 8. Year | 2015 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Lisa R. Westergaard |
Date | 10/20/2015 3:17:03 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
S. 1695, HR 3020 - FY 2016 appropriations increases for AHRQ, HRSA Title VII medicine training grants, NHSC: Federal spending priorities to support workforce, research.
No Bill No.-Health Resources and Services Administration HRSA FY 16 & 17 budget: Primary care practice-based research, patient safety, HIT.; preserving funding for AHRQ and Title VII in HRSA.
No Bill No.- Budget Control Act relief to end sequestration: Protect primary care spending.
No Bill No.-Oppose House draft FY16 bill to eliminate AHRQ; primary care practice-based research, patient safety, HIT.
No Bill No.-Reestablish annual appropriations for NHSC to address Health Professional Shortage Areas; Physician workforce shortages, Medical Student Debt.
No Bill No.-Oppose cuts to CMS in House draft FY16 bill; Competent administration of Medicare, Medicaid and CHIP.
No Bill No.-Robust investment in HRSA Title VII primary care physician training: primary care workforce.
No Bill No. - Title X, Family Planning Grants: Access to women's healthcare.
No Bill No. - CMS Program Management Funding: efficient federal health insurance programs.
No Bill No. - CMS Innovation Center: Support heath care delivery forums for the triple aim.
No Bill No. - Budget sequestration relief for non-defense discretionary programs: funding for AAFP priorities.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
|
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Kevin |
Burke |
|
Deputy Assistant Secretary at HHS |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
HR 2 - Reauthorize Teaching Health Center GME Program funding: maintain the sustainability of the THCGME program.
S. 1695, HR 3020 - FY 2016 appropriations increases for AHRQ, HRSA Title VII medicine training grants, NHSC: Federal spending priorities to support workforce, research.
No Bill No.-Graduate Medical Education: Advocate for introduction of a bill to require CMS to report data on residency positions; raise awareness and advocate for AAFP's policy proposals on GME.
No Bill No. - Health Resources and Services Administration HRSA FY 16 & 17 Budget: Primary care practice-based research, patient safety, HIT.
No Bill No. - Substance use disorders on youth athletes: Appropriate pain management, preventing opioid abuse.
No Bill No.-Primary care forum: Achieving the triple aim in health care.
No Bill No.-Advisory Committee on Training in Primary Care Medicine and Dentistry: Federal support for family medicine education and training.
No Bill No.-Innovative practices in Medication Assisted Treatment and Primary Care Coordination: Appropriate pain management, preventing opioid abuse.
No Bill No.-Robust investment in HRSA Title VII primary care physician training; primary care workforce.
No Bill No.-Graduate Medical Education: Explain and advocate for AAFP's GME proposal and support for the GAO transparency letter.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
|
Andrew |
Adair |
|
|
|
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Sonya |
Clay |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
HR 2-Reauthorize Teaching Health Center GME Program Funding: maintain the sustainability of the THCGME program to US.
HR 758- Lawsuit Abuse Reduction Act - Reducing frivolous lawsuits.
HR 1725-National All Schedules Prescription Electronic Reporting (NASPER) Reauthorization Act: Supporting prescription drug monitoring.
HR 2709-Brfing on Professional's Access to Health Workforce Integration Act: Pathway to licensure for health professionals immigrating to US.
HR 3020/S. 1695 - FY 2016 appropriations increases for AHRQ, HRSA Title VII medicine training grants, NHSC: Federal spending priorities to support workforce, research.
HR 3099/S. 1719: Recognize, Assist, Include, Support and Engage (RAISE) Family Caregivers Act: Creating and advisory board at HHS to develop a strategy to support family caregivers.
HR 3309: Further Flexibility in HIT Reporting and Advancing Interoperability (FLEX-IT 2) Act: Recasting the meaningful use of HIT program to emphasize interoperability and vendor responsibility.
HR 3656/S 2100-Tobacco to 21 Act: Raising the minimum age for buying tobacco to 21.
S. 1532-Affordability is Access Act: Supporting making over-the-counter contraceptives covered by insurance health plans.
S. 1893 - Mental Health Improvement Awareness Act: Removing barriers to improved mental health services in primary care settings.
S. 1989: Primary Care Enhancement Act: Removing impediments to broader use of Direct Primary Care.
No Bill No. - Chronic Care Management: advocate for introduction of bill to eliminate the Part B coinsurance.
No Bill No.- Health IT: Lobby to raise awareness of hardships created by implementation of Meaningful Use program; advocate for a pause on Stage 3, etc.
No Bill No.-Graduate Medical Education: Advocate for introduction of a bill to require CMS to report data on residency positions; raise awareness if AAFP's policy proposals on GME; support the GAO transparency letter.
No Bill No. - Health Resources and Services Administration HRSA FY 16 & 17 Budget: Primary care practice-based research, patient safety, HIT.
No Bill No. - Substance use disorders on youth athletes: Appropriate pain management, preventing opioid abuse.
No Bill No.-Primary care forum: Achieving the triple aim in health care.
No Bill No.-Advisory Committee on Training in Primary Care Medicine and Dentistry: Federal support for family medicine education and training.
No Bill No.-Innovative practices in Medication Assisted Treatment and Primary Care Coordination: Appropriate pain management, preventing opioid abuse.
No Bill No.-Oppose House draft FY16 bill to eliminate AHRQ: primary care practice-based research, patient safety, HIT.
No Bill No.-Reestablish annual appropriations for NHSC to address Health Professional Shortage Areas: Physician workforce shortages, Medical student debt.
No Bill No.-Robust investment in HRSA Title VII primary care physician training: primary care workforce.
No Bill No.-Title X, Family Planning Grants: access to women's health care.
No Bill No.-CMS Innovation Center: support health care delivery reforms for the triple aim.
No Bill No. - FP's as specialists for inpatient settings: Asking for changes so that FPs can consult with other FPs in inpatient settings.
No Bill No. - Health Insurer Mergers-Concern over mergers.
No Bill No.-Improving the Meaningful Use Program - Asking for interoperability and other changes to the Meaningful Use/HIT program.
No Bill No.-Tobacco Control: nicotine warning labels and child resistant packaging.
No Bill No.-HRSA Childhood vaccines: Nominated and FP to serve on a committee.
No Bill No.-EHRs: 2015 CEHRT proposal.
No Bill No.-Vaccines: Urge coverage of shingles and Tdap.
No Bill No.-Insulin Pen Availability: Insulin pens at same formulary level as injectable insulin.
No Bill No.-2016 proposed Medicare fee schedule: Commented on CMS proposed policy change for 2016; appropriate physician payment rules.
No Bill No.-Advance Care Planning: Support for advance care planning code.
No Bill No.-Medicaid Managed Care Policies: Commented on proposed changes to Medicaid managed care.
No Bill No.-Agricultural Appropriations Bill: retaining the Feb. 2007 date for FDA authority over tobacco products.
No Bill No. Trade Preferences Extension Act: opposing the use of reduction in Medicare provider payments to offset the cost of the bill.
No Bill No.-Chronic Disease Management reforms: Improving ways policies for Medicare beneficiaries with multiple chronic conditions.
No Bill No.-Repeal of the Affordable Care Act's Independent Advisory Board: Supporting the reform of the IPAB.
No Bill No.-Advanced Care Planning: Supporting CMS proposed rule to pay for advanced care planning.
No Bill No.-Consolidation of Health Insurance Plans: Expressing caution about proposed mergers of major insurance providers.
No Bill No.-Prescription Drug Abuse: Prioritizing prevention of prescription drug abuse.
No Bill No. - Tobacco Advertising: Asking for enforcement action against tobacco company that advertises "all Natural" cigarettes.
No Bill No.-Liquid Nicotine Packaging: Recommending FDA require child-proof packaging for liquid nicotine packages.
No Bill No.-Mental Health Reform: Advocated to eliminate insurance mental health carve outs.
No Bill No.-Health IT: Urged support for the FLEX-IT2 Act; stage 3 delay and Meaningful Use flexibility.
No Bill No.-Chronic Care Management Codes: Lobbying for potential legislation to eliminate patient co-pays associates with the CCMC.
No Bill No.-Health Insurance Marketplace Issues & Provider Involvement with Patient Enrollment: Network Adequacy, Patient Enrollment in Marketplaces.
No Bill No. - Children's Health Insurance - CHIP Program.
No Bill No. - Health Market Consolidation - Health Insurance consolidation, provider consolidation, hospital consolidation.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Office of Management & Budget (OMB), Office of Administration, Federal Trade Commission (FTC), Drug Enforcement Administration (DEA), Office of Natl Drug Control Policy (NDCP), Food & Drug Administration (FDA), Defense - Dept of (DOD), Justice - Dept of (DOJ), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
|
Andrew |
Adair |
|
|
|
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Robert |
Bennett |
|
|
|
Kevin |
Burke |
|
Deputy Assistant Secretary at HHS |
|
Shannon |
Morey |
|
|
|
Sonya |
Clay |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
HR 2-Reauthorize Teaching Health Center GME Program Funding: maintain the sustainability of the THCGME program.
HR 3309: Further Flexibility in HIT Reporting and Advancing Interoperability (FLEX-IT 2) Act: Recasting the meaningful use of HIT program to emphasize interoperability and vendor responsibility.
S. 1893 - Mental Health Improvement and Awareness Act: Removing barriers to improved mental health services in primary care settings.
S. 1989 - Primary Care Enhancement Act: Removing impediments to broader use of direct primary care.
No Bill No.- Chronic Care Management: advocate for introduction of bill to eliminate the Part B coinsurance.
No Bill No.-Health IT: Lobby to raise awareness of hardships created by implementation of Meaningful Use Program; advocate for a pause on stage 3, etc.
No Bill No.-Graduate Medical Education: Advocate for introduction of a bill to require CMS to report data on residency positions; raise awareness of AAFP's policy proposals on GME.
No Bill No. - Substance use disorders on youth athletes: Appropriate pain management, preventing opioid abuse.
No Bill No.-Primary care forum: Achieving the triple aim in health care.
No Bill No.-Innovative practices in Medication Assisted Treatment and Primary Care Coordination: Appropriate pain management, preventing opioid abuse.
No Bill No.-Oppose Cuts to CMS in House draft FY16 bill: Competent administration of Medicare, Medicaid and CHIP.
No Bill No. - CMS Program Management Funding: efficient federal health insurance programs.
No Bill No. - CMS Innovation Center: Support heath care delivery forums for the triple aim.
No Bill No. - Nominating FPs to govt agency committees: Getting FPs appointed to federal advisory committees.
No Bill No. - FP's as specialists for inpatient settings: Asking for changes so that FPs can consult with other FPs in inpatient settings.
No Bill No.-Improving the Meaningful Use Program - Asking for interoperability and other changes to the Meaningful Use/HIT program.
No Bill No.-2016 proposed Medicare fee schedule: Commented on CMS proposed policy change for 2016; appropriate physician payment rules.
No Bill No.-Advance Care Planning: Support for advance care planning code.
No Bill No.-Medicaid Managed Care Policies: Commented on proposed changes to Medicaid managed care.
No Bill No.-2016 proposed Medicare fee schedule: Commented on CMS proposed policy change for 2016; appropriate physician payment rules.
No Bill No. Trade Preferences Extension Act: opposing the use of reduction in Medicare provider payments to offset the cost of the bill.
No Bill No.-Chronic Disease Management reforms: Improving ways policies for Medicare beneficiaries with multiple chronic conditions.
No Bill No.-Repeal of the Affordable Care Act's Independent Advisory Board: Supporting the reform of the IPAB.
No Bill No.-Advanced Care Planning: Supporting CMS proposed rule to pay for advanced care planning.
No Bill No.-Health IT: Urged support for the FLEX-IT2 Act; stage 3 delay and Meaningful Use flexibility.
No Bill No.-Graduate Medical Education: Advocate for introduction of a bill to require CMS to report data on residency positions; raise awareness if AAFP's policy proposals on GME; support the GAO transparency letter.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), Health Resources & Services Administration (HRSA), Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Office of Natl Drug Control Policy (NDCP), Veterans Affairs - Dept of (VA), Government Accountability Office (GAO)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
|
Andrew |
Adair |
|
|
|
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Robert |
Bennett |
|
|
|
Kevin |
Burke |
|
Deputy Assistant at HHS |
|
Sonya |
Clay |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
HR 3656/S. 2100 - Tobacco to 21 Act: Raising the minimum age for buying tobacco to 21 years.
No Bill No. - Agriculture Appropriations Bill: retaining the Feb. 2007 date for FDA authority over tobacco products.
No Bill No. - Tobacco Advertising: Asking for enforcement action against tobacco company that advertises "all natural" cigarettes.
No Bill No. - Liquid Nicotine Packaging: Recommending FDA require child-proof packaging for liquid nicotine packages.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kevin |
Burke |
|
Deputy Assistant Secretary at HHS |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
HR 758-Lawsuit Abuse Reduction Act: Reducing frivolous lawsuits.
No Bill No.- Consolidation of Health Insurance Plans: Expressing caution about proposed mergers of major insurance providers.
No Bill No.-Health market consolidation; Health Insurance consolidation, provider consolidation, hospital consolidation.
17. House(s) of Congress and Federal agencies Check if None
Justice - Dept of (DOJ), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kevin |
Burke |
|
Deputy Assistant Secretary at HHS |
|
Shannon |
Morey |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
HR 2709-Breifing on Professional's Access to Health Workforce Integration: Pathway to licensure for health professionals immigrating to US.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
HR 1462 - Protecting our Infants Act: Authorizing AHRQ research on treatment and prevention of prenatal opioid abuse.
HR 3020 - Labor/HHS Appropriations Bill: Preserving funding for AHRQ and Title VII in HRSA.
S. 1532 Affordability is Access Act: Supporting making over the counter contraceptives covered by insurance health plans.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kevin |
Burke |
|
Deputy Assistant at HHS. |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
HR 1725-National All Schedules Prescription Electronic Reporting (NASPER) Reauthorization Act: Supporting prescription drug monitoring.
No Bill No.-Prescription Drug Abuse: prioritizing prevention of prescription drug abuse.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kevin |
Burke |
|
Deputy Assistant Secretary at HHS |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
No Bill No.-Health Market Consolidation: Health insurance consolidation, provider consolidation, hospital consolidation.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Shannon |
Morey |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |